Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 19, 2014 - Issue 1
Submit an article Journal homepage
436
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for acromegaly

Sylvère StörmannKlinikum der Universität München, Medizinische Klinik und Poliklinik IV, Ziemssenstr. 1, 80336 München, Germany+49 0 89 5160 2111; +49 0 89 5160 2194; [email protected]
&
Jochen SchopohlKlinikum der Universität München, Medizinische Klinik und Poliklinik IV, Ziemssenstr. 1, 80336 München, Germany+49 0 89 5160 2111; +49 0 89 5160 2194; [email protected]
Pages 79-97 | Published online: 28 Dec 2013

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Sylvère Störmann & Jochen Schopohl. (2020) Drug treatment strategies for secondary diabetes in patients with acromegaly. Expert Opinion on Pharmacotherapy 21:15, pages 1883-1895.
Read now
Daniel Cuevas-Ramos & Maria Fleseriu. (2016) Pasireotide: a novel treatment for patients with acromegaly. Drug Design, Development and Therapy 10, pages 227-239.
Read now
Sylvère Störmann & Jochen Schopohl. (2016) Perspectives on investigational drugs for acromegaly. Expert Opinion on Investigational Drugs 25:4, pages 381-384.
Read now
Cynthia Plunkett & Ariel L Barkan. (2015) The care continuum in acromegaly: how patients, nurses, and physicians can collaborate for successful treatment experiences. Patient Preference and Adherence 9, pages 1093-1099.
Read now
Andrea Giustina, Gherardo Mazziotti, Filippo Maffezzoni, Vito Amoroso & Alfredo Berruti. (2014) Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. Expert Opinion on Investigational Drugs 23:12, pages 1619-1635.
Read now

Articles from other publishers (4)

Sylvère Störmann & Thomas Cuny. (2023) The socioeconomic burden of acromegaly. European Journal of Endocrinology 189:2, pages R1-R10.
Crossref
Hainan Lan, Wei Li, Ruonan Li, Xin Zheng & Gan Luo. (2019) Endocytosis and Degradation of Pegvisomant and a Potential New Mechanism That Inhibits the Nuclear Translocation of GHR. The Journal of Clinical Endocrinology & Metabolism 104:6, pages 1887-1899.
Crossref
Rosa Maria Paragliola & Roberto Salvatori. (2018) Novel Somatostatin Receptor Ligands Therapies for Acromegaly. Frontiers in Endocrinology 9.
Crossref
Shlomo Melmed. (2015) New therapeutic agents for acromegaly. Nature Reviews Endocrinology 12:2, pages 90-98.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.